- Home
- Publications
- Publication Search
- Publication Details
Title
RORγ antagonists and inverse agonists: a patent review
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 27, Issue 1, Pages 101-112
Publisher
Informa UK Limited
Online
2016-09-15
DOI
10.1080/13543776.2017.1236918
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases
- (2016) George E. Fragoulis et al. Annual Review of Medicine
- Retinoid-related orphan receptor gamma t (RORγt) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742
- (2016) Christian Gege EXPERT OPINION ON THERAPEUTIC PATENTS
- ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
- (2016) Junjian Wang et al. NATURE MEDICINE
- Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin
- (2016) Susan H. Smith et al. PLoS One
- Discovery of N -(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists
- (2015) Yonghui Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- ROR Inverse Agonist Suppresses Insulitis and Prevents Hyperglycemia in a Mouse Model of Type 1 Diabetes
- (2015) Laura A. Solt et al. ENDOCRINOLOGY
- The psoriasis drugs market
- (2015) Salman Rizvi et al. NATURE REVIEWS DRUG DISCOVERY
- Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations
- (2015) S. Okada et al. SCIENCE
- Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors
- (2015) Yonghui Wang et al. ACS Medicinal Chemistry Letters
- SAR Exploration Guided by LE and Fsp3: Discovery of a Selective and Orally Efficacious RORγ Inhibitor
- (2015) Kazuyuki Hirata et al. ACS Medicinal Chemistry Letters
- ROR nuclear receptors: structures, related diseases and drug discovery
- (2014) Yan Zhang et al. ACTA PHARMACOLOGICA SINICA
- Inhibiting RORγt/Th17 axis for autoimmune disorders
- (2014) Fujio Isono et al. DRUG DISCOVERY TODAY
- Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms
- (2014) Sheng Xiao et al. IMMUNITY
- Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)
- (2014) Benjamin P. Fauber et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Th17 cells in autoimmune diseases
- (2014) Jianfei Yang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action
- (2014) Olivier René et al. ACS Medicinal Chemistry Letters
- Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors
- (2013) Yonghui Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists
- (2013) Ting Yang et al. ACS Medicinal Chemistry Letters
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started